X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs NATCO PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD NATCO PHARMA MERCK LTD/
NATCO PHARMA
 
P/E (TTM) x 26.4 32.8 80.4% View Chart
P/BV x 3.0 16.7 17.7% View Chart
Dividend Yield % 1.0 0.7 139.8%  

Financials

 MERCK LTD   NATCO PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
NATCO PHARMA
Mar-14
MERCK LTD/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060877 120.9%   
Low Rs623424 147.1%   
Sales per share (Unadj.) Rs632.4223.4 283.1%  
Earnings per share (Unadj.) Rs45.731.1 147.2%  
Cash flow per share (Unadj.) Rs62.340.3 154.7%  
Dividends per share (Unadj.) Rs11.005.00 220.0%  
Dividend yield (eoy) %1.30.8 170.0%  
Book value per share (Unadj.) Rs388.8219.5 177.1%  
Shares outstanding (eoy) m16.6033.07 50.2%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x1.32.9 45.7%   
Avg P/E ratio x18.420.9 87.9%  
P/CF ratio (eoy) x13.516.1 83.6%  
Price / Book Value ratio x2.23.0 73.1%  
Dividend payout %24.116.1 149.5%   
Avg Mkt Cap Rs m13,96921,504 65.0%   
No. of employees `0001.6NA-   
Total wages/salary Rs m1,4871,128 131.8%   
Avg. sales/employee Rs Th6,631.9NM-  
Avg. wages/employee Rs Th939.2NM-  
Avg. net profit/employee Rs Th479.4NM-  
INCOME DATA
Net Sales Rs m10,4987,389 142.1%  
Other income Rs m242167 145.1%   
Total revenues Rs m10,7417,556 142.1%   
Gross profit Rs m1,1351,793 63.3%  
Depreciation Rs m276304 90.5%   
Interest Rs m0366 0.0%   
Profit before tax Rs m1,1021,290 85.5%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343309 111.2%   
Profit after tax Rs m7591,027 73.9%  
Gross profit margin %10.824.3 44.6%  
Effective tax rate %31.123.9 130.1%   
Net profit margin %7.213.9 52.0%  
BALANCE SHEET DATA
Current assets Rs m6,4103,681 174.1%   
Current liabilities Rs m8,8283,123 282.7%   
Net working cap to sales %-23.07.6 -304.8%  
Current ratio x0.71.2 61.6%  
Inventory Days Days5889 64.5%  
Debtors Days Days3859 65.4%  
Net fixed assets Rs m1,4067,685 18.3%   
Share capital Rs m166331 50.2%   
"Free" reserves Rs m6,2866,670 94.2%   
Net worth Rs m6,4557,259 88.9%   
Long term debt Rs m0955 0.0%   
Total assets Rs m8,82811,957 73.8%  
Interest coverage xNM4.5-  
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.20.6 192.4%   
Return on assets %8.611.7 73.8%  
Return on equity %11.814.2 83.1%  
Return on capital %17.120.7 82.4%  
Exports to sales %8.339.4 21.0%   
Imports to sales %21.05.7 369.2%   
Exports (fob) Rs m8692,908 29.9%   
Imports (cif) Rs m2,209421 524.5%   
Fx inflow Rs m9593,445 27.8%   
Fx outflow Rs m2,612703 371.7%   
Net fx Rs m-1,6532,743 -60.3%   
CASH FLOW
From Operations Rs m1,0701,440 74.3%  
From Investments Rs m-750-1,089 68.8%  
From Financial Activity Rs m-150-353 42.5%  
Net Cashflow Rs m171-1 -11,469.8%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 51.8 1.5 3,523.8%  
Indian inst/Mut Fund % 18.2 7.8 232.1%  
FIIs % 1.0 16.6 6.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 26.0 111.9%  
Shareholders   28,591 25,395 112.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  CIPLA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 21, 2017 02:31 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - ALEMBIC PHARMA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS